- Home
- GDO vs INCR Comparison
GDO vs INCR Comparison
Compare GDO & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GDO | INCR |
|---|---|---|
| Founded | 2009 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.6M | 78.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GDO | INCR |
|---|---|---|
| Price | $11.73 | $1.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 39.4K | 14.4K |
| Earning Date | 01-01-0001 | 10-08-2025 |
| Dividend Yield | ★ 9.81% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $72,158,312.00 |
| Revenue This Year | N/A | $69.54 |
| Revenue Next Year | N/A | $41.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.21 | $1.22 |
| 52 Week High | $13.04 | $1.79 |
Technical Indicators
Market Signals| Indicator | GDO | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 55.98 | 48.70 |
| Support Level | $11.62 | $1.27 |
| Resistance Level | $11.78 | $1.38 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 93.75 | 69.98 |
Price Performance
Historical ComparisonAbout GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.